JD Health International (FRA:8ZN) EBITDA Margin % : 3.28% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is JD Health International EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. JD Health International's EBITDA for the six months ended in Dec. 2023 was €111 Mil. JD Health International's Revenue for the six months ended in Dec. 2023 was €3,393 Mil. Therefore, JD Health International's EBITDA margin for the quarter that ended in Dec. 2023 was 3.28%.

JD Health International EBITDA Margin % Historical Data

The historical data trend for JD Health International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International EBITDA Margin % Chart

JD Health International Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

-7.30

-87.92

-2.71

1.81

5.47

JD Health International Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial							-3.24	1.89	1.22	6.77	3.28

Competitive Comparison of JD Health International's EBITDA Margin %

For the Medical Care Facilities subindustry, JD Health International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JD Health International's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where JD Health International's EBITDA Margin % falls into.

JD Health International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

JD Health International's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	376.331	/	6874.731
	=	5.47 %

JD Health International's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	111.375	/	3393.011
	=	3.28 %

JD Health International (FRA:8ZN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

JD Health International EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of JD Health International's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (FRA:8ZN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (FRA:8ZN) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

JDHIY:USA JDHIF:USA 06618:Hong Kong 8ZN:Germany

Address

No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111

Website

https://ir.jdhealth.com

JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (FRA:8ZN) Headlines

No Headlines